What the FDA Says

These documents are either from or about the FDA and its concerns about clinical trials. What’s more important is that the concerns addressed within these articles can all be addressed with the capabilities of the Remarque Systems Platform.

• Speech Transforming FDAs Approach to Digital Health
• FDA Draft RBM monitoring
• FDA Seeks More Efficent Clinical Research Strategies to Lower Drug Costs